The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

See photos from this year's Summer Meeting.

Certificate in Non-Clinical Psychopharmacology

Registration is open for the Non-Clinical Certificate in Cambridge 4th - 8th March 2018
Read More

Summer Meeting 2018

Join us in London 22nd to 25th July 2018
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

External Event BAP Session BAP Event BAP Stand

All Events

25th January 2018 Anxiety Disorders The Bristol Hotel, Prince Street, Bristol
4th March 2018 Certificate in Non-Clinical Psychopharmacology - Residential Course The Royal Cambridge Hotel
22nd March 2018 Child and Adolescent Psychopharmacology Park Plaza Hotel, Maid Marian Way, Nottingham

Clinical Certificate | Masterclasses | Non-Clinical Certificate


Journal of Psychopharmacology and Therapeutic Advances in Psychopharmacology
By Susan Lord
Posted on 18th December 2017

Open Access A large number of new gold open access (OA) journals have been launched in recent years to provide immediate open access to research at the point of publication. It is estimated that 16% of peer reviewed journals are now gold OA. These use funding models that do not charge the reader or institution […]

How functional neuroimaging is informing cognitive neurobiological models of auditory verbal hallucinations
By Thomas Dunne
Posted on 11th October 2017

Introduction Auditory verbal hallucinations (AVHs), or “hearing voices”, are a complex phenomenon characterised by abnormal perceptions of speech occurring in the absence of an appropriate external stimulus.1 Hallucinations of this modality hold great diagnostic significance, with Schneider’s (1959) first-rank symptoms of schizophrenia (including AVHs) still recognised today by major classification systems such as the International […]

Not just a four-letter word: The role of neuroendocrine factors in romantic love
By Thomas Dunne
Posted on 25th September 2017

The dopamine reward pathwayIntroduction In his poem ‘Love’s Trinity’, Victorian poet laureate Alfred Austin presents a holistic view of love, describing its impact on both our psyche and physiology:1,2 ‘Soul, heart, and body, we thus singly name, Are not in love divisible and distinct, But each with each inseparably link’d’ (A Austin).3 Romantic love has influenced literature and […]

See more articles


Barbara Sahakian
Naked Scientist: Smart Drugs: What's the deal?
Barbara was interviewed by Naked Scientist about 'smart drugs'
7th November 2017

Sarah Bailey
New drug shows potential as a different kind of antidepressant in mouse trials
Sarah Bailey and her team have developed a potential new antidepressant and antianxiety treatment with a unique mechanism of action
6th November 2017

Stephen Lawrie
Life of a Scientist - Doing Bright Club!
Stephen performs at Bright Club at The Stand Comedy Club in Edinburgh in this vlog (08:25 - 10:26)
31st October 2017

Michael Browning and Erdem Pulcu
Wired: This computer model is unlocking why people suffer from depression
Michael Browning and BAP Summer Meeting poster prize winner Erdem Pulcu were interviewed by wired UK about their study that was presented at the Summer Meeting
19th October 2017

Hip Hop Psych (Akeem Sule and Becky Inkster)
Journal of Hip Hop Studies: Eminem’s Character, Stan: A Bio-PsychoSocial Autopsy
Akeem and Becky wrote an article for the Journal of Hip Hop Studies on Eminem's character, Stan
13th October 2017

See more media


Professor Carmine Pariante awarded Distinguished Investigator Grant
15th December 2017

BAP Council Member Prof Carmine Pariante (IoPPN), awarded a Distinguished Investigator Grant by the Brain & Behavior Research Foundation
Read More
Unlicensed applications of licensed drugs in psychiatric practice: RCPsych and BAP work together to produce new guidance
7th December 2017

Unlicensed applications of licensed drugs in psychiatric practice: RCPsych and BAP work together to produce new guidance
Read More
Professor Trevor Robbins receives the 2017 Goldman-Rakic Award
4th July 2017

We are pleased to announce that Professor Trevor Robbins has been elected to receive the 2017 Goldman-Rakic Award
Read More
Bill Deakin to Receive 2017 BAP Lifetime Achievement Award
14th June 2017

We are delighted to announce that the recipient of the 2017 BAP Lifetime Achievement Award is Professor Bill Deakin from Manchester.
Read More

See more news


Journal of Psychopharmacology

Most recent articles:

Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice

Journal of Psychopharmacology, Volume 31, Issue 12, Page 1511-1518, December 2017.

A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding

Journal of Psychopharmacology, Volume 31, Issue 12, Page 1519-1526, December 2017.

The effects of AMPA receptor blockade on resting magnetoencephalography recordings

Journal of Psychopharmacology, Volume 31, Issue 12, Page 1527-1536, December 2017.

Journal Website

Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.